Unlock instant, AI-driven research and patent intelligence for your innovation.

Preparation methods of tyrosine kinase inhibitor and intermediates thereof

A technology of solvents and mixed solvents, applied in the direction of organic chemistry, etc., can solve the problems of unfavorable industrial production, cumbersome preparation, and high cost

Active Publication Date: 2014-08-06
CHIA TAI TIANQING PHARMA GRP
View PDF6 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] At present, there are mainly patents such as CN102227164A and CN102282134A about its synthetic route report, and the specific synthetic route is summarized as follows: In CN102227164A, 4-chloro-6-methoxy-7-[[3-(morpholin-4-yl) propyl] Oxy]quinoline and N-(3-fluoro-4-hydroxyphenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide are directly condensed, but the synthesis process has two There are two disadvantages: one is that the condensation reaction must use expensive palladium catalyst and nitrogen protection, which is not conducive to industrial production; the other is that the intermediate N-(3-fluoro-4-hydroxyphenyl)-N'-(4-fluorophenyl ) The preparation of cyclopropane-1,1-dicarboxamide is relatively cumbersome. After 1,1-cyclopropylmalonic acid reacts with quantitative p-fluoroaniline, it is prepared by reacting with 4-amino-2-fluorophenol, which is easy A by-product of N-(4-fluorophenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
[0008] In CN102282134A, 4-chloro-6-methoxyl group-7-[[3-(morpholine-4-yl) propyl group] oxygen group] quinoline is first combined with 2-fluoro- 4-Nitrophenol is condensed, then ferric acid (ammonium) reduces the nitro group to generate an amino group, and then condenses with acid chloride to prepare Foretinib, in which potassium tert-butoxide is condensed with a strong base and then ferric acid (ammonium) is reduced, and the reaction conditions are more severe. Great pollution to the environment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation methods of tyrosine kinase inhibitor and intermediates thereof
  • Preparation methods of tyrosine kinase inhibitor and intermediates thereof
  • Preparation methods of tyrosine kinase inhibitor and intermediates thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0124] Example 1 Preparation of 1-(ethoxycarbonyl)cyclopropanecarboxylic acid

[0125]

[0126] Add 200ml of methanol and 30g of diethyl 1,1-cyclopropanedicarboxylate into a 500ml three-necked flask, cool to 10°C, add sodium hydroxide solution (6.4g of NaOH, 32ml of water) dropwise under stirring, and react at room temperature for 3 hours , the reaction was completed, and the solvent was evaporated under reduced pressure to obtain a white solid. 200 ml of water and 150 ml of ethyl acetate were added to the solid, the layers were stirred and separated, and the organic phase was discarded. The aqueous layer was adjusted to pH 3-4 with 2mol / L hydrochloric acid, extracted with ethyl acetate (200ml×2), dried with anhydrous sodium sulfate, filtered, and evaporated to remove the solvent under reduced pressure to obtain 20.0g of a colorless translucent oil (78.5%).

Embodiment 2

[0127] Example 2 Preparation of ethyl 1-[(3-fluoro-4-hydroxyphenyl)carbamoyl]cyclopropanecarboxylate

[0128]

[0129] Add 20 g of 1-(ethoxycarbonyl)cyclopropanecarboxylic acid and 200 ml of tetrahydrofuran prepared in Example 1 into a 500 ml three-necked flask, cool to 0-10°C, add 18.0 ml of thionyl chloride dropwise, and stir at 0-10°C After 2h, after the reaction, the solvent was distilled off under reduced pressure to obtain a colorless translucent oil. 100 ml of tetrahydrofuran was added to the oil for later use.

[0130] Add 300ml of tetrahydrofuran, 28.8g of 4-amino-2-fluorophenol and 26.5ml of triethylamine into a 1L three-necked flask, add the reaction solution dropwise at 0-10°C, and react at room temperature for 2 hours. After filtration, the filtrate was evaporated to remove the solvent under reduced pressure. Add ethyl acetate (300ml) and 2mol / L hydrochloric acid (200ml) to the residue, stir and separate layers, wash the organic phase with 2mol / L hydrochloric...

Embodiment 3

[0134] Example 3 1-[3-fluoro-4-[[6-methoxy-7-[[3-(morpholin-4-yl)propyl]oxy]quinolin-4-yl]oxy] Preparation of ethyl phenyl]cyclopropane-1,1-dicarboxamide formate

[0135]

[0136] Add 4-chloro-6-methoxy-7-[[3-(morpholin-4-yl) propyl] oxygen group] oxy] quinoline 13.5g in the three-necked bottle of 250ml, DMAP 9.8g and embodiment 2 10.7 g of the prepared ethyl 1-[(3-fluoro-4-hydroxyphenyl)carbamoyl]cyclopropanecarboxylate and 50 ml of 2,6-lutidine were stirred and heated to 140°C. After reacting for 3 hours, add 300ml of dichloromethane to the reaction solution cooled to room temperature, dissolve and wash with 1mol / L hydrochloric acid (200ml×2), 2mol / L KOH (200ml×3), and dry the organic phase with anhydrous sodium sulfate. After filtration, the solvent was evaporated under reduced pressure, and column chromatography (mobile phase V / V: dichloromethane / methanol=10 / 1) gave 8.4 g (37.0%) of a yellow solid.

[0137] m.p.91.9~92.1℃;

[0138] MS: 568.4 ([M+H] + );

[0139] 1...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides preparation methods of a tyrosine kinase inhibitor and intermediates thereof, specifically preparation methods of N-[3-fluoro-4-[[6-methoxy-7-[oxy]quinolin-4-yl]oxy]phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide (Foretinib), and analogs and intermediates thereof. 1,1-cyclopropane dicarboxylic acid diester is used as the raw material to prepare a compound of the formula VI; and the compound of the formula VI is hydrolyzed and then reacts with a compound of the formula VIII, so as to prepare the Foretinib and the analogs thereof. The condition of each reaction step is mild, the preparation method is easy to operate, the price of the raw materials is low, and thus the production cost is reduced, the yield is relatively high, and the preparation methods are suitable for industrialized production.

Description

technical field [0001] The present invention relates to the fields of organic chemistry and medicinal chemistry, in particular, the present invention relates to N-[3-fluoro-4-[[6-methoxy-7-[[3-(morpholin-4-yl)propyl ]oxy]quinolin-4-yl]oxy]phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide (Foretinib), its analogues and intermediates Preparation. Background technique [0002] Protein tyrosine kinases (PTKs) play an extremely important role in cell signal transduction pathways, and can regulate a series of physiological and biochemical processes such as cell growth, differentiation, and apoptosis. Studies have shown that the overexpression and activation of protein tyrosine kinase receptors lead to the disorder of cell proliferation regulation, which leads to the occurrence of tumors, and is also closely related to tumor invasion and metastasis, tumor angiogenesis, and tumor radiotherapy and chemotherapy resistance relevant. Effectively inhibiting the activity of pro...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D215/233C07C233/60
CPCC07C233/60C07D215/22
Inventor 赵锐李新路孟庆义张喜全史祥飞
Owner CHIA TAI TIANQING PHARMA GRP